| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |